Most fiber explainers start with a split that isn’t quite right. They divide fiber into soluble and insoluble, assign health effects to each category, and stop there. The framing is tidy. It’s also a crude map of a more complicated territory, and if you follow it too literally you end up with supplements that don’t do what you expect.
A better framing uses two axes instead of one: viscosity (does the fiber form a gel in water?) and fermentability (do gut bacteria eat it?). We wrote about that 2x2 in our guide to soluble and insoluble fiber because it predicts clinical effects more accurately. Viscous fibers slow glucose absorption and lower LDL. Fermentable fibers feed gut bacteria and produce short-chain fatty acids. Most of what people care about in a fiber supplement falls out of those two questions. The broader context — that most Europeans already have a significant fiber deficit — is what makes these distinctions practically important, not just academic.
But even the 2x2 hides two physical variables that matter a lot in practice. Particle size, for insoluble fibers like wheat bran. Degree of polymerization, for fermentable fibers like chicory inulin. Both are invisible on a product label. Both are the reason two products with nearly identical ingredient lists can feel like completely different fibers.
How much does particle size actually matter?
Insoluble fiber works mechanically. It adds bulk, holds water, stimulates the stretch receptors in the colon that trigger a bowel movement. Solubility isn’t the whole story for how well it does that job. The physical size of the particles matters, and the clinical evidence on wheat bran is older than most people realize.
In a controlled metabolic study published in 1980, healthy young men were given 32 g per day of either coarse or finely ground wheat bran on an otherwise low-fiber diet.1 The brans were chemically identical. Only the grind was different. Coarse bran produced a mean transit time of around 42 hours. Fine bran produced around 58 hours. Daily fecal wet weight was 14 percent higher on coarse bran, and the moisture content of the stool was higher too (75.2 percent vs. 72.3 percent). The number of bowel movements per day didn’t change, but everything that happened inside the gut did.
The proposed mechanisms are physical, not chemical. Coarser bran particles hold more water. They’re harder for gut bacteria to digest, so more of the fiber survives to the distal colon still doing its mechanical job. And larger particles trap more of the gas that fermentation produces, adding to stool bulk.2
The picture got more interesting in 1999. A crossover trial in healthy adults compared wheat brans with mean particle sizes of roughly 50 µm vs. 758 µm at 19 g per day.3 This time, both brans increased fecal bulk significantly over control, and the difference between coarse and fine bulking effects was not statistically significant. But fine bran produced notably more fecal butyrate, more butyrate output, and more methane on the breath, all markers of increased bacterial fermentation. Finely ground bran was being eaten by gut bacteria in a way that coarse bran wasn’t.
So particle size doesn’t deliver a single winner. It delivers a tradeoff. Coarse bran is better for mechanical action: faster transit, more water in the stool, more bulk per gram. Fine bran is better for producing butyrate, the short-chain fatty acid that feeds colonocytes and supports the colon lining. Neither is “correct.” They’re optimized for different outcomes.
The label “wheat bran” tells you almost none of this. Two supplements can list wheat bran as their only ingredient and produce different clinical effects.
What is degree of polymerization, and why does it matter for inulin?
For fermentable fibers, the equivalent hidden variable is chain length. Degree of polymerization (DP) is just the count of sugar units linked together in a single fiber molecule. A DP of 3 means three sugars in a chain. A DP of 30 means thirty. Same molecular family, different length, different behavior.
Chicory inulin is the case where this matters most, because it’s sold in two very different forms that often share the same name on a label. Standard chicory inulin has a DP range of roughly 2 to 60.4 Short-chain fructooligosaccharides, often labeled FOS or oligofructose, have a DP under 10. Long-chain or “high-performance” inulin has the short fractions removed, so what’s left is DP 10 and above.
Chain length determines where in the gut the fiber gets fermented, and how fast. In the SHIME model (a well-validated in vitro simulator of the human colon), short-chain oligofructose ferments rapidly in the proximal colon.5 Long-chain inulin ferments more slowly and reaches further down the colon, including the distal segments where most of the gut’s butyrate production happens and where disease risk concentrates. The same study found that long-chain inulin produced higher total short-chain fatty acid output and lower proteolytic activity than oligofructose over time, even though oligofructose showed effects sooner.
The practical translation is direct. Short-chain FOS gives you more gas, faster. It ferments in a rush, high in the colon, where the fermentation products are most likely to reach the stomach and the small intestine before they’re absorbed. That’s why oligofructose is a classic FODMAP trigger and why people with sensitive guts often react badly to it even at modest doses. Long-chain inulin ferments gentler and deeper, which is less dramatic in the short term but arguably more useful for the parts of the colon where outcomes matter most.
This is also why the EFSA-authorized chicory inulin health claim specifies mean DP ≥ 9. The EFSA Panel didn’t evaluate “inulin” in the abstract. They evaluated “native chicory inulin,” defined in the scientific opinion as a non-fractionated mixture with a mean degree of polymerization of at least 9.6 The authorized claim, “Chicory inulin contributes to normal bowel function by increasing stool frequency,” applies to that specific material at 12 g per day. It is not automatically transferable to a shorter-chain FOS product, even if both are sourced from the same chicory root.
Why isn’t this on the label?
Particle size and DP both affect clinical outcomes, and neither is usually disclosed. There are structural reasons.
Particle size is variable across batches of the same product, because grinding is a mechanical process and mills don’t produce a single particle size — they produce a distribution. Reporting a number would require reporting a distribution, which doesn’t fit on a supplement label. DP is also a distribution, not a single value, and the honest way to describe it (mean DP, or DP range with percentages) requires more chemistry literacy than most consumers bring to a supplement aisle.
These are real reasons, but they’re not good reasons for the information to be completely absent. The EFSA chicory inulin file shows it can be done: the ingredient is defined by its DP profile, the claim is tied to that profile, and the regulator enforces it. Most consumer products aren’t operating at that standard because they don’t have to.
The practical conclusion for readers comparing supplements: the word “inulin” on a label tells you less than you think, and the word “wheat bran” tells you even less. If a product is making specific claims about bowel function, ask whether it matches the EFSA specification (mean DP ≥ 9, native chicory). If it’s a bran-based product, the grind matters as much as the gram count. And if a product is cagey about both, assume it’s cagey for a reason.
For a deeper look at chicory inulin specifically, including how the EFSA dossier was built and what the 12 g/day condition of use actually refers to, see our full piece on the science of chicory inulin.
Footnotes
-
Heller SN, Hackler LR, Rivers JM, et al. Dietary fiber: the effect of particle size of wheat bran on colonic function in young adult men. Am J Clin Nutr. 1980;33(8):1734-1744. https://pubmed.ncbi.nlm.nih.gov/6250395/ ↩
-
Brodribb AJ, Groves C. Effect of bran particle size on stool weight. Gut. 1978;19(1):60-63. https://gut.bmj.com/content/19/1/60 ↩
-
Jenkins DJA, Kendall CWC, Vuksan V, et al. The effect of wheat bran particle size on laxation and colonic fermentation. J Am Coll Nutr. 1999;18(4):339-345. https://pubmed.ncbi.nlm.nih.gov/12038477/ ↩
-
Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ. Inulin, a flexible oligosaccharide I: Review of its physicochemical characteristics. Carbohydr Polym. 2015;130:405-419. ↩
-
Van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 2007;102(2):452-460. https://pubmed.ncbi.nlm.nih.gov/17241351/ ↩
-
EFSA NDA Panel. Scientific Opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006. EFSA Journal. 2015;13(1):3951. https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2015.3951 ↩